Clinical diagnosis and treatment progress of primary duodenal cancer
10.3760/cma.j.cn115355-20200528-00286
- VernacularTitle:原发性十二指肠癌的临床诊治进展
- Author:
Zhengqin GENG
1
;
Lin XIE
;
Rong LI
;
Yedan LIAO
;
Ling ZHOU
;
Jiadai TANG
;
Xueqi ZHANG
Author Information
1. 云南省肿瘤医院 昆明医科大学第三附属医院消化肿瘤内科，昆明 650118
- From:
Cancer Research and Clinic
2020;32(10):730-733
- CountryChina
- Language:Chinese
-
Abstract:
Duodenal cancer is a clinically rare gastrointestinal malignant tumor. Its early symptoms lack specificity, making it difficult to diagnose clinically and easy to be misdiagnosed and missed. The treatment of duodenal cancer is mainly surgery, supplemented by radiotherapy and chemotherapy. Most patients have already experienced local invasion or distant metastasis at the time of first diagnosis, and lack of effective treatment, the prognosis is extremely poor. In recent years, a series of studies have pointed out that targeted therapy and immunotherapy can improve the prognosis of patients with duodenal cancer. This article reviews the progress of diagnosis and treatment of duodenal cancer, hoping to help guide clinical diagnosis and treatment and develop new treatment options.
